T. Ohkusa et al., EFFECTS OF DANTROLENE SODIUM ON PROGRESSION OF LEFT-VENTRICULAR HYPERTROPHY INDUCED BY PRESSURE-OVERLOAD IN RATS, Journal of cardiovascular pharmacology, 31(4), 1998, pp. 520-524
We studied the long-term effects of dantrolene sodium (D), a specific
sarcoplasmic reticulum (SR) Ca2+-release inhibitor, on the progression
of left ventricular pressure-overloaded hypertrophy in rats. We treat
ed abdominal aorta-constricted rats with one of two doses of D for 3 w
eeks. The extent of hypertrophy was expressed as the ratio of left ven
tricle to body weight. Hemodynamic parameters were measured by using a
microtip catheter manometer. Although a low dose of D (500 mg/L in dr
inking water) decreased blood pressure to normal levels, the progressi
on of cardiac hypertrophy was not inhibited. In contrast, a high dose
of D (5 mg/kg, i.p.) also reduced blood pressure and inhibited the pro
gression of cardiac hypertrophy. Dantrolene sodium had no effect on ca
rdiac function in sham-operated rats. Thus control of Ca2+ release fro
m the SR might be crucial in regulating the progression of cardiac hyp
ertrophy, the final mediator possibly being intracellular Ca2+ concent
ration.